Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer
T. Tominaga(Showa University), Yasuo Ohashi(Chuo University), Yo Sasaki(SHOWA Medical University), Masakazu Toi(Mukogawa Women's University), Toshikazu Suwa(Saitama Red Cross Hospital), I Adachi(National Cancer Center Hospital East), Toshio Tabei(Saitama Cancer Center), Y Takatsuka(Kansai Rosai Hospital), Tadashi Ikeda(Keio University)
Cited by 39
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
|Journal of Clinical Oncology|2017|1.7k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k